Department of Research & Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.
Department of Public Health, Erasmus University Medical Centre, Rotterdam, the Netherlands.
Cancer Epidemiol. 2021 Apr;71(Pt A):101897. doi: 10.1016/j.canep.2021.101897. Epub 2021 Jan 20.
Previous studies describe a large variation in the proportion of patients undergoing treatment with curative intent for esophageal (EC) and gastric cancer (GC). Since centralization of surgical care was initiated and more awareness regarding hospital practice variation was potentially present, we hypothesized that hospital practice variation for potentially curable EC and GC patients changed over time.
Patients with potentially curable EC (n = 10,115) or GC (n = 3988) diagnosed between 2012-2017 were selected from the Netherlands Cancer Registry. Multilevel multivariable logistic regression was used to analyze the differences in the probability of treatment with curative intent between hospitals of diagnosis over time, comparing 2012-2014 with 2015-2017. Relative survival (RS) between hospitals with different probabilities of treatment with curative intent were compared.
The range of proportions of patients undergoing treatment with curative intent per hospital of diagnosis for EC was 45-95 % in 2012-2014 and 54-89 % in 2015-2017, and for GC 52-100 % and 45-100 %. The adjusted variation declined for EC with Odds Ratios ranging from 0.50 to 1.72 between centers in the first period to 0.70-1.44 in the second period (p < 0.001) and did not change for GC (Odds Ratios ranging from 0.78 to 1.23 to 0.82-1.23, (p = 1.00)). A higher probability of treatment with curative intent was associated with a better survival for both malignancies.
Although substantial variation between hospitals of diagnosis in the probability in receiving treatment with curative intent still exists for both malignancies, it has decreased for EC. A low probability of receiving curative treatment remained associated with worse survival.
先前的研究表明,接受根治性治疗的食管(EC)和胃癌(GC)患者比例存在较大差异。由于手术治疗的集中化已经开始,并且对医院实践差异的认识可能有所提高,我们假设对于潜在可治愈的 EC 和 GC 患者,医院实践差异随时间发生了变化。
从荷兰癌症登记处中选择了 2012-2017 年间诊断为潜在可治愈 EC(n=10115)或 GC(n=3988)的患者。使用多水平多变量逻辑回归分析了不同诊断医院随时间治疗意愿的差异,比较了 2012-2014 年和 2015-2017 年。比较了不同有根治性治疗意愿的医院之间的相对生存率(RS)。
2012-2014 年和 2015-2017 年,每个诊断医院接受根治性治疗的患者比例范围分别为 EC 的 45-95%和 54-89%,GC 的 52-100%和 45-100%。EC 的调整后的变异程度降低,中心之间的优势比范围从第一阶段的 0.50 到 1.72 到第二阶段的 0.70 到 1.44(p<0.001),而 GC 则没有变化(优势比范围为 0.78 到 1.23 到 0.82 到 1.23,(p=1.00))。更高的根治性治疗可能性与两种恶性肿瘤的生存更好相关。
尽管两种恶性肿瘤的诊断医院之间接受根治性治疗的可能性仍存在较大差异,但 EC 的差异已降低。接受根治性治疗的可能性较低仍然与较差的生存相关。